Permanent neonatal diabetes mellitus in China

BMC Pediatrics

Guan-pin Dong¹  Jun-feng Fu¹  Li Liang²  Ke Huang¹ 

[1] Department of Endocrinology, Children’s Hospital of Zhejiang University School of Medicine, 57 Zhugan Xiang, Hangzhou 310003, China;Department of Pediatrics, The First Affiliated Hospital of Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China

关键词: Therapy;    Genetic analysis;    Permanent neonatal diabetes mellitus;   

Others  :  1135417
DOI  :  10.1186/1471-2431-14-188

 received in 2014-01-16, accepted in 2014-07-18,  发布年份 2014

【 摘 要 】

Background

Permanent neonatal diabetes mellitus (PNDM) is a rare disease, which is defined as the onset of diabetes before the age of 6 months with persistence through life. Infants with KCNJ11 or ABCC8 genetic mutations may respond to oral sulfonylurea therapy. Currently, there are limited studies about the genetic analysis and long-term follow-up of PNDM.

Case presentation

We report four cases of PNDM. None of the infants or their parents had INS, KCNJ11, or ABCC8 genetic mutations. One infant underwent continuous subcutaneous insulin infusion (CSII) and the other infants underwent multiple injections of insulin (MII). In these infants, PNDM persisted from 35 months to 60 months of follow-up. Three infants maintained fairly stable blood sugar levels, and one infant had poor sugar control.

Conclusions

We suggest that all of the infants with PNDM should undergo genetic evaluation. For infants without KCNJ11 and ABCC8 genetic mutations, oral sulfonylurea should not be considered as treatment. CSII is a useful method for overcoming the difficulties of diabetes, and it may also improve the quality of life of both infants and their parents.

【 授权许可】

   
2014 Huang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 2.

【 参考文献 】

• [1]Karges B, Meissner T, Icks A, Kapellen T, Holl RW: Management of diabetes mellitus in infants. Nat Rev Endocrinol 2012, 8(4):201-211.
• [2]Kanakatti Shankar R, Pihoker C, Dolan LM, Standiford D, Badaru A, Dabelea D, Rodriguez B, Black MH, Imperatore G, Hattersley A, Ellard S, Gilliam LK, SEARCH for Diabetes in Youth Study Group: Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study. Pediatr Diabetes 2013, 14(3):174-180.
• [3]Edghill EL, Flanagan SE, Ellard S: Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11. Rev Endocr Metab Disord 2010, 11(3):193-198.
• [4]Yang WL, Sang YM, Liu M, Gu Y, Zhu C, Ni GC: [Clinical analysis of permanent neonatal diabetes mellitus in 10 cases]. Zhongguo Dang Dai Er Ke Za Zhi 2012, 14(2):144-146.
• [5]Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Søvik O, Polak M, Hattersley AT, Neonatal Diabetes International Collaborative Group: Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006, 355(5):467-477.
• [6]Klupa T, Skupien J, Mirkiewicz-Sieradzka B, Gach A, Noczynska A, Zubkiewicz-Kucharska A, Szalecki M, Kozek E, Nazim J, Mlynarski W, Malecki MT: Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up. Diabetes Technol Ther 2010, 12(5):387-391.
• [7]Takahashi A, Nagashima K, Hamasaki A, Kuwamura N, Kawasaki Y, Ikeda H, Yamada Y, Inagaki N, Seino Y: Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase. Diabetes Res Clin Pract 2007, 77(3):343-350.
• [8]Li YH, Yuan TM, Yu HM: Neonatal diabetes mellitus in China: a case report and review of the Chinese literature. Clin Pediatr 2012, 51(4):366-373.
• [9]Beardsall K, Pesterfield CL, Acerini CL: Neonatal diabetes and insulin pump therapy. Arch Dis Child Fetal Neonatal Ed 2011, 96(3):F223-F224.
• [10]Olinder AL, Kernell A, Smide B: Treatment with CSII in two infants with neonatal diabetes mellitus. Pediatr Diabetes 2006, 7(5):284-288.
• [11]Polak M, Shield J: Neonatal and very-early-onset diabetes mellitus. Semin Neonatol 2004, 9(1):59-65.